| Autor: |
Akıncı S; Department of Cardiology, Alanya Application and Research Center, Başkent University Faculty of Medicine, Antalya, Turkey., Çoner A; Department of Cardiology, Alanya Application and Research Center, Başkent University Faculty of Medicine, Antalya, Turkey., Akbay E; Department of Cardiology, Alanya Application and Research Center, Başkent University Faculty of Medicine, Antalya, Turkey., Adar A; Department of Cardiology, Alanya Application and Research Center, Başkent University Faculty of Medicine, Antalya, Turkey., Müderrisoğlu H; Department of Cardiology, Başkent University Faculty of Medicine, Ankara, Turkey. |
| Jazyk: |
angličtina |
| Zdroj: |
Metabolic syndrome and related disorders [Metab Syndr Relat Disord] 2022 Sep; Vol. 20 (7), pp. 421-427. Date of Electronic Publication: 2022 May 12. |
| DOI: |
10.1089/met.2021.0121 |
| Abstrakt: |
Background: The atherogenic index of plasma (AIP) is an indicator of atherogenic dyslipidemia and is significantly associated with the development of atherosclerotic cardiovascular disease. Previous studies showing the association of AIP with C-reactive protein (CRP) and microalbuminuria included hypertensive and diabetic patients. We aimed to determine the association of AIP with CRP and albuminuria in a normotensive and nondiabetic population. Methods: The study was conducted retrospectively. Two hundred thirty-three individuals without hypertension, diabetes, cardiovascular disease, malignancy, systemic inflammatory disease, nephrological disease, and active infection were determined and included in the study. Urinary albumin excretion was calculated from the albumin-creatinine ratio in fresh spot urine [urinary albumin-creatinine ratio (UACR)]. AIP risk groups were compared in terms of clinical and laboratory findings, and the correlation between AIP and CRP and UACR was evaluated. Results: A total of 233 people, with a mean age of 45.4 years and 139 (69.7%) of whom were male, were included in the study. One hundred thirty-eight (59.2%) individuals were found to be in the low-risk group, 29 (12.5%) in the medium-risk group, and 66 (28.3%) in the high-risk group, according to the AIP value. CRP and UACR were not different between the AIP risk groups ( P : 0.141 and 0.441, respectively). A mild correlation was found between AIP and CRP ( r : 0.192; P : 0.003), but no correlation was found between AIP and UACR ( r : 0.086; P : 0.193). The stepwise linear regression analysis with model adjusted for possible confounders and AIP revealed that only body mass index was a significant predictor of CRP ( β : 0.308; P < 0.001), while only systolic blood pressure was a significant predictor of UACR (β: 0.19; P : 0.004), but AIP was not. Conclusions: AIP was not associated with CRP and UACR in normotensive and nondiabetic individuals. This finding suggests that the relationship found in previous studies is related to the presence of hypertension or diabetes rather than the AIP. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
